EMIR was enacted following the G20 summit commitment to having all standardised OTC derivatives cleared through central clearing counterparties by the end of 2012. While Europe still lags a year or so behind the U.S., it is starting to see the core provisions gradually coming into effect and firms must ensure that they fully understand the requirements to avoid being caught out. Optima guides clients through all the various requirements under EMIR and has actively participated in industry working groups. We proactively reach out and advise on impending rules and regulations ensuring that our clients are ahead of the pack in terms of understanding, being prepared for and having procedures to meet with new regulations whilst simultaneously minimising the impact where possible.